Chronic myeloid leukemia (CML) is a type of blood cancer. The number of people with CML who are living well is growing. This is due to new treatments. Six new CML drugs have been approved since 2024. Other new treatments are being studied in clinical trials. Progress toward a cure is under way.
new drugs for SPRYCEL helps to fulfill a need for second-line treatments for CML patients with resistance or intolerance to Gleevec.
The new approval not only approximately doubles the drug's eligible treatment Conquering CML: The Breakthrough Paradigm Change of Treatment-
CML Gold Standard SOHO 2024 For Treatment Value, Imatinib Remains the CML Gold Standard New Trials ESC 2024 Time Antihypertensives Taken Doesn't Matter: New
New Drugs for CML; Update on the French and German Interferon combination studies; Age-adjusted treatment in CML- Elderly and Pregnancy report for young CML
The main treatment for CML is tyrosine kinase inhibitors (TKIs) test new treatments, such as new chemotherapy drugs or targeted therapies
The FDA has cleared an investigational new drug application for TERN-701 as a treatment for patients with chronic myeloid leukemia (CML).
Scientists continue to look for new drugs to treat CML, especially CML that no longer responds to TKIs. In some people, CML cells develop a change in the BCR-ABL oncogene known as a T315I mutation, which makes them resistant to many of the TKI drugs used today.
It's a valuable new treatment option for leukemia patients, Cortes said. Ponatinib is the third drug approved by the FDA for CML and PhALL
Comments